Policy News
-
Utah COVID-19 Grant Programs Update
BioUtah is pleased to provide the life sciences community with a current summary of state COVID-19 initiatives and…
-
Trump Administration Releases COVID-19 Vaccine Distribution Strategy
The Administration on Wednesday released a detailed plan for the distribution of free COVID-19 vaccines beginning next year.…
-
President Signs New Executive Order on Drug Pricing
President Trump issued a new “Most-Favored-Nations” (MFN) executive order on September 13 that links U.S.-paid Medicare drug prices…
-
Recursion Partners with Bayer to Accelerate Drug Discovery, Secures Series D Funding
In a double header of good news, Salt Lake City -based Recursion announced on Wednesday that the company…
-
Clene Nanomedicine Raises Series D Financing of $42.5 Million
SALT LAKE CITY, August 26, 2020 – Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced that it…
-
HHS Determines FDA Can’t Regulate Lab-Developed Tests Without Formal Rulemaking
HHS said yesterday that it has determined that the FDA will not require premarket review of laboratory-developed tests…
-
BioUtah and Utah Biotech/Biopharma Companies Raise Concerns About Impact of Trump’s “Most-Favored-Nation” Drug Pricing Order on Innovation
BioUtah, along with 10 Utah biotech and biopharma companies, have sent letters to Utah’s U.S. Senators and Representatives…
-
Recursion and University of Utah Launch Altitude Lab, Largest Life Sciences Incubator in Utah
On August 11, Altitude Lab, founded by BioUtah member Recursion and the University of Utah’s Center for Technology…
-
House Bill Introduced to Provide COVID-19 Economic Relief to Startups
Bipartisan legislation to help entrepreneurs and startups navigate the economic perils of COVID-19, has been introduced in the…
-
RAPS Convergence 2020 — live online!
Convergence is the largest annual gathering of regulatory professionals, regulators, scientists, and innovators from around the world and…
-
Senate Republicans Release HEALS Act – COVID-19 Stimulus Package
Earlier this week, Senate Majority Leader Mitch McConnell released the Republican version of a fourth COVID-19 package (or…
-
President Trump Signs Drug Pricing Executive Orders, Touts “Most Favored Nation” Pricing
Last Friday, President Trump signed four executive orders aimed at lowering drug prices, including an order that would…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
